| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
Champoux Jennifer serves as a Chief Operating Officer at GLUE. Across recent SEC filings that breaks down to 0 buys and 6 sells. Those positions are worth an estimated $1.5M at current prices.
The biggest single holding is GLUE (~$1.5M) as Chief Operating Officer. The recent filings there lean toward selling, a net 15,682 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Chief Operating Officer | Sale+OE10b5-1 | 4,351 | $23.38 | $101,729.86 | -6.5% | -57.8% | - | |
| Jun 23, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Chief Operating Officer | Sale+OE10b5-1 | 2,175 | $20.00 | $43,500.00 | -3.4% | -40.8% | - | |
| Jun 17, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Chief Operating Officer | Sale+OE10b5-1 | 2,176 | $19.00 | $41,344.00 | -3.4% | -29.4% | - | |
| May 27, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Chief Operating Officer | Sale+OE10b5-1 | 2,175 | $20.00 | $43,500.00 | -3.4% | -24.0% | - | |
| May 22, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Chief Operating Officer | Sale+OE10b5-1 | 2,176 | $19.00 | $41,344.00 | -3.4% | -21.4% | - | |
| Jan 5, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Chief Operating Officer | Sell | 2,629 | $15.17 | $39,881.93 | -4.0% | +17.6% | - |